Literature DB >> 17219336

[Recurrent facial paresis with facial neurinoma].

E Scholz1, J Langer, K Begall.   

Abstract

PATIENT: A clinical case of a 49-year-old man is described who presented with a right facial paresis for 4 weeks. The patient had undergone a decompression of facial nerve and a radical mastoidectomy elsewhere in 1998 because of a facial paresis and acute mastoiditis. In the following years a complete right facial paresis occurred several times improving with prednisolone. In addition to topognostic examinations a high resolution computed tomography of the temporal bone was made. CT showed a mass in the right tympanic cavity with close contact to the ossicular chain. Diagnostic tympanotomy disclosed a tumor of the tympanic segment of the facial nerve. Pathological examination indicated a diagnosis of neurinoma with an Antoni B architecture. In a second operation the tumor was resected totally and a facial nerve reconstruction was performed by a greater auricular nerve interposition graft. Seven month postoperative beginning nerve reinnervation was seen proceeding continually until the control examination after 1 1/2 year. DISCUSSION: Facial neurinoma are a rare course of facial paresis. There are no specific symptoms. That's why the diagnosis is difficult. But it is necessary to think of with differential diagnosis of facial paresis.

Entities:  

Mesh:

Year:  2007        PMID: 17219336     DOI: 10.1055/s-2006-944986

Source DB:  PubMed          Journal:  Laryngorhinootologie        ISSN: 0935-8943            Impact factor:   1.057


  2 in total

1.  Subtotal facial nerve decompression in preventing further recurrence and promoting facial nerve recovery of severe idiopathic recurrent facial palsy.

Authors:  Shu-hui Wu; Xiang Chen; Jie Wang; Hua Liu; Xiao-zhong Qian; Xin-liang Pan
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-03-12       Impact factor: 2.503

2.  The effect of total facial nerve decompression in preventing further recurrence of idiopathic recurrent facial palsy.

Authors:  Yang Li; Zhi Li; Cheng Yan; Liu Hui
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-02-04       Impact factor: 2.503

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.